Hedge Fund - Caligan Partners
Verona Pharma Plc (VRNA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $91,227,384 | 19.04% | 1,436,878 | $59.82 |
| 2 | 2024 - Q4 (2024-12-31) | $66,728,614 | 16.89% | 1,436,878 | $37.54 |
| 3 | 2024 - Q3 (2024-09-30) | $41,338,980 | 13.1% | 1,436,878 | $24.61 |
| 4 | 2024 - Q2 (2024-06-30) | $26,660,712 | 6.23% | 1,843,756 | $14.60 |
| 5 | 2024 - Q1 (2024-03-31) | $20,859,832 | 5.51% | 1,296,447 | $17.29 |
| 6 | 2023 - Q4 (2023-12-31) | $3,639,312 | 1.22% | 183,064 | $14.77 |
| 7 | 2023 - Q3 (2023-09-30) | $2,983,943 | 1.37% | 183,064 | $19.26 |
| 8 | 2023 - Q2 (2023-06-30) | $3,869,973 | 2.17% | 183,064 | $21.33 |
| 9 | 2023 - Q1 (2023-03-31) | $3,675,925 | 2.56% | 183,064 | $21.59 |
| 10 | 2022 - Q4 (2022-12-31) | $4,783,462 | 3.98% | 183,064 | $13.32 |
The displayed share prices are average quarterly stock market prices.